Table 4 Univariate and multivariate analyses of ANRIL expression between control and case group.

From: Expression ratio of circular to linear ANRIL in hypertensive patients with coronary artery disease

 

Control

Case

Unadjusted P

P*

P**

P***

Circular ANRIL

1.00 ± 0.43

0.76 ± 0.37

0.042

0.081

0.043

0.157

Linear ANRIL

1.00 ± 0.64

2.86 ± 1.65

 < 0.0001

0.001

0.015

0.043

Circular/Linear ANRIL

1.00 ± 0.51

0.39 ± 044

 < 0.0001

0.003

0.010

0.053

  1. Bold values imply statistical significance.
  2. *Adjusted for age, sex, and BMI.
  3. **Adjusted for age, sex, BMI, diabetes, dyslipidemia, and hypertension.
  4. ***Adjusted for age, sex, BMI, diabetes, dyslipidemia, hypertension, smoking Habit, and history of atherosclerosis.